Pfizer Limited (BOM:500680)
India · Delayed Price · Currency is INR 4,822.80
+23.75 (0.49%)
At close: Jul 31, 2026
Pfizer Market Cap
Pfizer has a market cap or net worth of 220.68 billion as of July 31, 2026. Its market cap has decreased by -8.30% in one year.
Market Cap
220.68B
Enterprise Value
190.50B
Revenue
25.70B
Ranking
n/a
PE Ratio
30.02
Stock Price
4,822.80
ChartMarket Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 220.68B, an increase of 568.42%. That is a compound annual growth rate of 7.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 220.68B | -3.28% |
| Dec 31, 2025 | 228.18B | -5.56% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 590.39B |
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |
| AstraZeneca Pharma India | 202.59B |
| Caplin Point Laboratories | 191.15B |
| Jubilant Pharmova | 148.07B |